Setting the record straight in the reply by DiMasi, Hansen and Grabowski

Journal of Health Economics

Volumn 24, Issue 5, 2005, Pages 1045-1048

  Light, Donald W ^a,b   Warburton, Rebecca N ^c   DiMasi, Joseph A ^d   Hansen, Ronald W ^e   Grabowski, Henry G ^f  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF VICTORIA   (Canada)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DRUG COST; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH SURVEY; LAW; MEDICAL RESEARCH; NOTE; RELIABILITY; VALIDATION PROCESS;

EID: 23944484301     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2005.07.003     Document Type: Note

References (0)